
Standing Ovation inks exlusive partnership with Bel Group
Just one month after Standing Ovation SA won the start-up pitch at INDUSTRIA BIOTEC and got a €16m Series A financing, the two-year old company has...

Step Pharma presents promising cancer treatment
Since September 2022, STP938, the cancer inhibitor developed by Step Pharma SAS, has been undergoing clinical trials for the treatment of T and B...

CatalYm GmbH raises €50m to push visugromab development
Following a €60m Series B financing in 2020, Martinsried-based CatalYm GmbH announced the closing of a Series C financing round of €50m. The...

Roche withdraws checkpoint blocker from the market
Switzerland’s Hoffmann La Roche AG no longer markets its cancer immunotherapy atezolizumab (Tecentriq) for the treatment of urothelial carcinoma in...

New polymer can stop biofilm formation
The acrylate co-polymer reported by Jean-Frédéric Dubern and colleagues in Science Advances (doi: 10.1126/sciadv.add7474) have the potential to...

Numares AG cashes in €20m from EIB
The European Investment Bank (EIB) announced to invest up to €20m "quasi-equity" loan in German Numares Health AG. The Regensburg-based...

Fungal skin replaces plastics in electronics
In a proof-of-concept study, Doris Danninger and colleagues demonstrate that fungal mycelium skins can be grown and processed to serve as substrates...